Fred Alger Management, LLC Puma Biotechnology, Inc. Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $7.04 Million - $16.3 Million	-2,470,965 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.63 - $9.39 $3.41 Million - $4.84 Million	-515,011 Reduced 17.25%	2,470,965 $17.3 Million
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $5.75 Million - $7.43 Million	-640,661 Reduced 17.67%	2,985,976 $27.4 Million
Q1 2021 May 17, 2021	BUY	$9.38 - $13.63 $1.98 Million - $2.87 Million	210,634 Added 6.17%	3,626,637 $35.3 Million
Q4 2020 Feb 16, 2021	BUY	$7.78 - $12.13 $649,474 - $1.01 Million	83,480 Added 2.51%	3,416,003 $35 Million
Q3 2020 Nov 13, 2020	BUY	$9.5 - $11.14 $8.16 Million - $9.56 Million	858,494 Added 34.7%	3,332,523 $33.6 Million
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $974,824 - $1.84 Million	139,062 Added 5.96%	2,474,029 $25.8 Million
Q1 2020 May 15, 2020	BUY	$6.28 - $14.57 $3.54 Million - $8.21 Million	563,782 Added 31.83%	2,334,967 $19.7 Million
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $679,289 - $1.12 Million	104,506 Added 6.27%	1,771,185 $15.5 Million
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $4.2 Million - $6.16 Million	479,743 Added 40.42%	1,666,679 $17.9 Million
Q2 2019 Aug 14, 2019	SELL	$12.3 - $35.76 $45,989 - $133,706	-3,739 Reduced 0.31%	1,186,936 $15.1 Million
Q1 2019 May 14, 2019	BUY	$20.77 - $42.37 $7.66 Million - $15.6 Million	368,634 Added 44.84%	1,190,675 $46.2 Million
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $1.59 Million - $3.7 Million	-79,141 Reduced 8.78%	822,041 $16.7 Million
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $21.3 Million - $30.9 Million	516,344 Added 134.17%	901,182 $41.3 Million
Q2 2018 Jul 19, 2018	BUY	$48.3 - $68.25 $6.08 Million - $8.59 Million	125,815 Added 48.57%	384,838 $22.8 Million
Q1 2018 May 10, 2018	BUY	$59.7 - $99.25 $4.06 Million - $6.76 Million	68,088 Added 35.66%	259,023 $17.6 Million
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $358,225 - $505,561	3,817 Added 2.04%	190,935 $18.9 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $13.5 Million - $22.4 Million	187,118	187,118 $22.4 Million

Others Institutions Holding PBYI

# of Institutions

101

Shares Held

29M

Call Options Held

50.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$9.85 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$9.68 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$8.3 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$7.81 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.34 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $123M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account